Is it Safe to Buy Salesforce Stock Right Now? | CRM STock Analysis
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 25 Sept 2026, 12:45 UTC
- Recorded by Tahlil Plus
- 25 Sept 2026, 13:58 UTC

AI-generated source summary
Salesforce (CRM) has demonstrated significant operational improvements, with its operating margin (TTM) reaching 21.52%, a substantial increase from previous years. This growth is attributed to strategic business restructuring in 2022, cost controls, and the integration of AI technologies into its services, which has improved average selling prices. Despite past concerns about AI disrupting the market, Salesforce has successfully leveraged AI, including offerings from OpenAI, to enhance its platform and maintain customer loyalty. The company's return on invested capital has reached a record high of 12.74%. While the stock experienced a significant decline earlier in the year, dropping below $150 in mid-June, it has since recovered and is now trading above $230. The forward price-to-earnings ratio is at 14.58, near historic lows, suggesting potential undervaluation. Based on a discounted cash flow analysis, the intrinsic value per share is estimated at $279.60, presenting an approximate 19.85% upside potential from the current market price of $233.28 over the next 12-18 months.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
